EUVIMEDEUVIMED entdecken
Crossref

Higher Circulating Resistin Levels Linked to Increased Sarcopenia Risk in Older Adults

Mi Kyung Kwak, Ji Yeon Baek, So Jeong Park, Hee-Won Jung iD, Eunju Lee, Il-Young Jang iD, Eunhye Ji, Eun-Gyoung Hong, Yunju Jo, Dongryeol Ryu, Beom-Jun Kim iD

The Journal of Clinical Endocrinology & Metabolism · 07.08.2025 · 110 (9) · e2994-e3001

DOI: 10.1210/clinem/dgae894 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 25.12.2024. Verfasst von Mi Kyung Kwak und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do 18450, South …. Hauptthemen laut MEDLINE: Sarcopenia, Resistin. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Korean ARPA-H Project through the Korea Health Industry Development Institute, Ministry of Health & Welfare, Republic of Korea, the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Experimental evidence indicates that resistin, an adipokine, negatively impacts muscle metabolism by hindering myogenesis.

Objective

To explore resistin's potential as a biomarker of muscle health in humans by examining the relationship between circulating resistin levels and sarcopenia in older adults. Design and Setting A case-control study conducted in a geriatric clinical unit.

Participants

The study included 247 individuals aged 65 and older who underwent comprehensive geriatric evaluations. Main Outcome Measures Sarcopenia was defined based on Asian-specific thresholds, with serum resistin concentrations measured using an ELISA.

Results

After adjusting for sex, age, fat mass, smoking, osteoarthritis, and diabetes, participants with sarcopenia, low muscle mass, and weak muscle strength exhibited at least 27.0% higher circulating resistin concentrations than controls (P = .002-.003). Elevated serum resistin levels were inversely associated with skeletal muscle mass, gait speed, and the short physical performance battery score and positively associated with the time to complete 5 chair stands (P = .019-.048). Higher serum resistin levels were linked to an increased risk of sarcopenia, low muscle mass, and weak muscle strength (all P = .005). Finally, participants in the highest resistin quartile had at least 3 times higher odds of having adverse muscle outcomes compared to those in the lowest quartile (P = .007-.029).

Conclusion

This study set out to establish a link between blood resistin levels and sarcopenia, suggesting that circulating resistin may serve as a potential biomarker reflecting poor muscle health in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaResistinHumansAgedFemaleMaleCase-Control StudiesBiomarkersAged, 80 and overMuscle, SkeletalMuscle StrengthRisk FactorsGeriatric Assessment

Stichwörter der Autor:innen

adipokineagingbiomarkerresistinsarcopenia

Substanzen

ResistinBiomarkersRETN protein, human

Autor:innen und Institutionen

  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Gyeonggi-do 18450, South Korea.
  • Division of Geriatrics, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, South Korea.
  • Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, South Korea.
  • Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology, Gwangju 61005, South Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, South Korea.

ORCID-Profile: Hee-Won Jung, Il-Young Jang, Beom-Jun Kim

Förderung

  • Korean ARPA-H Project through the Korea Health Industry Development Institute
  • Ministry of Health & Welfare, Republic of Korea
  • the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea
  • the National Research Foundation of Korea
  • South Korean government (MSIT)
  • Hallym University Medical Center Research Fund

Zitieren

APA

Kwak, M. K., Baek, J. Y., Park, S. J., Jung, H. W., Lee, E., Jang, I. Y., Ji, E., Hong, E. G., Jo, Y., Ryu, D., & Kim, B. J. (2025). Higher Circulating Resistin Levels Linked to Increased Sarcopenia Risk in Older Adults. The Journal of Clinical Endocrinology & Metabolism, 110(9), e2994-e3001. https://doi.org/10.1210/clinem/dgae894

Vancouver

Kwak MK, Baek JY, Park SJ, Jung HW, Lee E, Jang IY, et al. Higher Circulating Resistin Levels Linked to Increased Sarcopenia Risk in Older Adults. The Journal of Clinical Endocrinology & Metabolism. 2025;110(9):e2994-e3001. doi:10.1210/clinem/dgae894

BibTeX
@article{Kwak2025,
  author = {Kwak, Mi Kyung and Baek, Ji Yeon and Park, So Jeong and Jung, Hee-Won and Lee, Eunju and Jang, Il-Young and Ji, Eunhye and Hong, Eun-Gyoung and Jo, Yunju and Ryu, Dongryeol and Kim, Beom-Jun},
  title = {Higher Circulating Resistin Levels Linked to Increased Sarcopenia Risk in Older Adults},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {9},
  pages = {e2994--e3001},
  doi = {10.1210/clinem/dgae894}
}
Kostenlos starten →